Latest 10-Q quarterly reports
NYSE
Eversource Energy reported a significant drop in second-quarter earnings, primarily due to charges related to the sale of Aquarion, increased offshore wind liabilities, and a FERC ROE refund, despite operational revenue growth.
NYSE
Alamo Group Inc. announced its second quarter 2026 financial results, showing revenue growth driven by acquisitions, but a slight decrease in net income and EPS compared to the prior year.
NASDAQ
CRISPR Therapeutics AG filed its Form 10-Q for the quarter ended June 30, 2026, detailing advancements in its gene-editing therapies, including CASGEVY, alongside financial performance and strategic updates.
NYSE
Easterly Government Properties, Inc. (DEA) filed its Form 10-Q for the quarter ended June 30, 2026, detailing revenue growth driven by property acquisitions and new developments, alongside a decrease in net income.
OQB
NEWH
Newhydrogen, INCNewHydrogen, Inc. filed its Q2 2026 10-Q, reporting continued operating losses and substantial doubt about its ability to continue as a going concern, despite ongoing development of its green hydrogen technology.
NYSE
Tidewater Inc. reported mixed results for Q2 2026, with revenue growth driven by strong performance in the Europe/Mediterranean segment, though overall costs increased due to geopolitical factors and acquisition-related expenses.
NYSE
3D Systems Corporation's Q2 2026 filing reveals a slight revenue increase, but a decrease in gross profit and a net loss, alongside significant operational changes and an equity raise.
NASDAQ
INDV
Indivior PLCIndivior Pharmaceuticals announced robust Q2 2026 financial results with a 14% revenue increase, driven by SUBLOCADE, and significant progress on its merger with Supernus Pharmaceuticals.
NYSE
CRD-A
Crawford & COCrawford & Company's Q2 2026 filing shows increased net income and segment operating earnings, despite a slight dip in total revenues.
NYSE
Jackson Financial Inc. announced robust Q2 2026 results, driven by significant growth in Retail Annuities and improved net investment income.
NYSE
The Williams Companies, Inc. (WMB) announced robust financial results for the second quarter of 2026, driven by increased service revenues and strategic asset management.
NASDAQ
AIMD
Ainos, INCAinos, Inc. reported a substantial decrease in revenue and a widening net loss for the second quarter of 2026, primarily due to a strategic shift away from VELDONA pet supplements towards its AI Nose platform, which is still in early commercialization stages.
NASDAQ
Oric Pharmaceuticals disclosed its second-quarter 2026 financial results, highlighting progress in its rinzimetostat and enozertinib clinical programs while reporting a net loss of $41.5 million.
NASDAQ
GeneDx Holdings Corp. announced its Q2 2026 financial results, showing an 11% increase in total revenue to $114.4 million, but also a net loss of $17.7 million.
NASDAQ
FreightCar America's Q2 2026 results show a decline in revenues and gross profit, with a significant net loss driven by warrant liability revaluation and increased expenses.
NYSE
BRCC
Brc INCBRC Inc. reported a 13% increase in Q2 2026 revenue to $107.0 million, with operating income turning positive, though gross margin faced headwinds.
OQB
Viskase Holdings, Inc. reported a net loss of $5.13 million for the second quarter of 2026, with net sales decreasing by 7.3% year-over-year, while facing substantial doubt regarding its ability to continue as a going concern.
NYSE
Bowhead Specialty Holdings Inc. announced a significant increase in gross written premiums and net income for the second quarter of 2026, driven by growth across its underwriting divisions.
NYSE
Inventrust Properties Corp. announced its Q2 2026 results, showcasing a notable increase in lease income and same-property Net Operating Income (NOI), driven by strategic acquisitions and rent escalations.
NYSE
Vitesse Energy, Inc. announced a significant increase in total revenue for the second quarter of 2026, driven by higher oil prices and a strategic acquisition, though a notable derivative loss impacted the year-to-date results.
NASDAQ
Advanced Energy Industries, Inc. announced robust Q2 2026 results with a 30% revenue increase, driven by AI-related demand in Data Center Computing and Semiconductor Equipment markets, alongside improved gross margins.
NASDAQ
Capital Southwest Corporation reports increased investment income and a growing portfolio, while navigating market volatility and managing debt.
NASDAQ
Electronic Arts announced a 19% year-over-year revenue increase to $1.986 billion for the first quarter of fiscal year 2027, driven by strong performance in full game downloads and live services, alongside significant progress towards its acquisition by an investor consortium.
NASDAQ
Jazz Pharmaceuticals plc announced its second quarter 2026 financial results, showcasing significant revenue increases driven by its key sleep and epilepsy medications, alongside progress in its oncology pipeline.
NYSE
CNH Industrial N.V. reported a decrease in net income for the second quarter of 2026 compared to the prior year, driven by higher costs and a challenging agricultural market, though construction segment revenue saw significant growth.
NASDAQ
Stoke Therapeutics reported a net loss of $61.6 million for Q2 2026, with revenue down significantly year-over-year, while advancing its zorevunersen and STK-002 programs.
NYSE
Inspire Medical Systems announced Q2 2026 results showing a revenue decrease driven by U.S. market challenges, while also detailing ongoing legal proceedings and a new strategic growth plan.
NASDAQ
BLZE
Backblaze, INCBackblaze, Inc. announced a 18% increase in total revenue for Q2 2026, driven by a 34% surge in B2 Cloud Storage revenue, alongside improved gross margins.
NASDAQ
Financial Institutions, Inc. reported a significant increase in net income and net interest income for the second quarter of 2026, driven by loan growth and improved net interest margin.
NASDAQ
Keros Therapeutics, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing ongoing clinical development, financial performance, and risk factors.